Related Experiment Video
Updated: Aug 21, 2026

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
Published on: September 14, 2014
HAART drugs induce mitochondrial damage and intercellular gaps and gp120 causes apoptosis
Milan Fiala1, Thomas Murphy, James MacDougall
1Department of Medicine, Greater Los Angeles VA Medical Center, Los Angeles, CA, USA.
Insights
Human immunodeficiency virus (HIV-1) and its proteins cause heart cell death and damage mitochondria. Highly active antiretroviral therapy (HAART) drugs also harm heart cells and blood vessels.
Area of Science:
- Cardiovascular Science
- Infectious Diseases
- Toxicology
Background:
- HIV-1 infection is linked to cardiovascular issues, but the specific roles of the virus, its proteins, and treatments like HAART are unclear.
- While HAART reduces heart disease risk, it can cause metabolic problems and potentially coronary artery disease.
Purpose of the Study:
- To investigate the toxic effects of HIV-1, HIV-1 glycoprotein 120 (gp120), and HAART drugs on heart and endothelial cells.
- To understand the mechanisms behind HIV-1 and HAART-related cardiovascular complications.
Main Methods:
- Assessed apoptosis in neonatal rat ventricular myocytes (NRVMs) and human coronary artery endothelial cells (CAECs) exposed to HIV-1, gp120, and azidothymidine (AZT).
- Examined mitochondrial damage in cardiomyocytes.
- Measured intercellular gaps and transendothelial electrical resistance in endothelial cells treated with HAART drugs.
Main Results:
- HIV-1 and gp120 induced apoptosis in NRVMs and CAECs, while AZT did not.
- Ethylisothiourea, a nitric oxide synthase inhibitor, reduced gp120-induced apoptosis.
- AZT, HIV-1, and gp120 damaged cardiomyocyte mitochondria.
- HAART drugs (AZT, indinavir) created gaps in endothelial cells and reduced electrical resistance.
Conclusions:
- HIV-1 and gp120 directly cause cardiomyocyte and endothelial cell apoptosis, contributing to cardiovascular toxicity.
- HAART medications can disrupt endothelial cell structure and mitochondria, potentially leading to vascular damage.
Abstract:
HIV-1 infection is associated with serious cardiovascular complications, but the roles of HIV-1, viral proteins, and highly active antiretroviral therapy (HAART) drugs are not understood. HAART decreases the overall risk of heart disease but leads to metabolic disturbances and possibly coronary artery disease. We investigated toxicities of HIV-1, HIV-1 glycoprotein 120 (gp120), and HAART drugs for human coronary artery endothelial cells (CAECs), brain microvascular endothelial cells, and neonatal rat ventricular myocytes (NRVMs). HIV-1 and gp120, but not azidothymidine (AZT), induced apoptosis of NRVMs and CAECs. Ethylisothiourea, an inhibitor of nitric oxide synthase, inhibited apoptosis induction by gp120. AZT, HIV-1, and gp120 all damaged mitochondria of cardiomyocytes. HAART drugs, AZT, and indinavir, but not HIV-1, produced intercellular gaps between confluent endothelial cells and decreased transendothelial electrical resistance. In conclusion, HIV-1 and gp120 induce toxicity through induction of cardiomyocyte and endothelial cell apoptosis. HAART drugs disrupt endothelial cell junctions and mitochondria and could cause vascular damage.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Retrovirus Life Cycles
Drug toxicity: Drug–Drug Interaction
Cryptococcal Meningitis
Desensitization and Tachyphylaxis
Several...

